Welcome to our dedicated page for WOLTERS KLUWER S/ADR news (Ticker: WTKWY), a resource for investors and traders seeking the latest updates and insights on WOLTERS KLUWER S/ADR stock.
Wolters Kluwer issues news about its global professional information, software, and services business, represented in the U.S. by the WTKWY sponsored Level 1 ADR. Updates commonly cover healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG solutions.
Recurring items include trading updates by business area, annual report and AGM materials, Supervisory Board and executive changes, dividend proposals, portfolio actions, and technology investments. Company announcements also track AI-enabled offerings and platforms such as FAB, Expert AI capabilities in CCH Axcess and UpToDate, legal technology products including Legisway and Kleos, and cloud automation tools such as CodaBox, ClearFacts, Kyte, and Flowin.
Summary not available.
Wolters Kluwer, Health announced that Legacy Health has chosen Simplifi 797 for compliance support in cleanroom operations across eight facilities. The platform aims to standardize medication compounding, enhancing staff and patient safety in accordance with USP guidelines (795, 797, 800). Legacy Health recognized inefficiencies in their previous systems and seeks to leverage Simplifi 797 to improve oversight and real-time compliance tracking. This initiative highlights Legacy’s commitment to safety and accountability in pharmacy operations.
Wolters Kluwer has successfully completed the capital reduction approved at the Annual General Meeting on April 22, 2021. The company has cancelled 5,000,000 ordinary shares, reducing the total issued shares to 262,516,153. Following the cancellation, 2,763,928 shares remain in treasury, representing 1.05% of the total issued shares. Wolters Kluwer's operations span over 40 countries, with annual revenues of €4.6 billion reported for 2020. The company’s shares are traded on Euronext Amsterdam under the ticker WKL and the U.S. ADRs trade as WTKWY.
Wolters Kluwer Tax & Accounting discusses state tax deduction limits stemming from the Tax Cuts and Jobs Act of 2017, highlighting attempts by various states to help residents maximize state and local tax benefits.
The article emphasizes Connecticut's pioneering legislation allowing pass-through entity taxation while detailing challenges in other states regarding planning and compliance. The IRS has indicated support for such measures, but varying state laws create complexity for businesses. Legislative changes may affect these workarounds, particularly with a potential expiration of the federal deduction limit after 2025.
Wolters Kluwer will host the TeamMate Live 2021 virtual conference from September 20-22, focusing on agile audit practices. The event will connect audit professionals globally to discuss the transformation of internal audit through digital and analytical strategies. Keynote speaker Tom Wujec will address building high-performing teams. The conference includes over 40 sessions covering industry trends and best practices, emphasizing the need for internal audit teams to deliver greater value amidst emerging risks.
Summary not available.
Wolters Kluwer Tax & Accounting has launched a library of Audit Data Analytics Resources to assist CPA firms in transitioning from traditional audit methods to real-time transaction analysis. This initiative aims to enhance audit quality and efficiency, offering resources developed by auditors for auditors, including blogs and video testimonials. The TeamMate® Analytics solution simplifies audit automation, reportedly reducing audit test times by up to 90%. Wolters Kluwer, a global leader in professional services, recorded €4.6 billion in revenue in 2020.
Wolters Kluwer highlights recent CDC recommendations for additional COVID-19 vaccine doses for immunocompromised individuals and the White House's suggestion for a booster shot eight months after the second dose. Kristen Nichols, a pharmacist, emphasizes the distinction between booster shots, meant to enhance waning immunity in healthy individuals, and additional doses for those who may not have responded adequately to initial vaccinations. This initiative aims to improve immune responses and provide critical protection against COVID-19.
Summary not available.
Summary not available.